Narrative review / 2014
A review notes that sugar-sweetened beverage consumption plays a role in the epidemic of obesity, metabolic syndrome, and fatty liver disease.
This narrative review examined data on dietary sugar consumption and related health risks, including NHANES, USDA surveys, meta-analyses, and randomized controlled trials. About 75% of foods and beverages contain added sugar, and soft drink consumption has increased fivefold since 1950. Meta-analyses indicate sugar-sweetened beverage (SSB) intake is related to risks of diabetes, metabolic syndrome, and cardiovascular disease, and drinking two 16-ounce SSBs daily for 6 months induced metabolic syndrome features and fatty liver. Trials lasting 6 months to 2 years showed that lowering soft drink intake reduced weight gain.
- Study type
- Narrative review
- Who was studied
- Children and adults (survey, trial, and meta-analysis data)
- What was measured
- Obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, fatty liver
THE PAPER
Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.
Bray GA, Popkin BM. Diabetes Care, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.